THE consensus among internists, surgeons, and anesthetists today is that patients with heart disease fare well when anesthetized. Although this is primarily a clinical impression, there is a growing volume of literature to support this thesis. One must distinguish, however, between patients with heart disease who are undergoing surgery on other organ systems and those who are to undergo cardiac surgery itself. It is not easy to gather data on this subject because of the difficulty in comparing anesthetic morbidity and mortality in like groups of patients. For example, one clinic might examine the results of an anesthetic techniie employed for mitral valvuloplasty and find no mortality, whereas another group might find the mortality to be 15 or 20 per cent. The explanation for this difference probably would be that in the first report the individuals anesthetized and operated on had relatively benign mitral stenosis while in the second, the patients might have fallen into a group IV functional classification.' Thus the first consideration in evaluating the effects of anesthesia must be the severity of the heart disease.
In discussing anesthetic agents and technics it is well to remember that usually it is the skill with which an anesthetic is given rather than the choice of a particular agent that determines the safety of the procedure. Likewise the other phases of the operation are just as important as the anesthetic in the outcome. It should not be forgotten that anesthesia is but a small part of the total surgical experience. Atropine or its congeners are used coin inonly to inhibit salivary secretion and to block untoward vagal influences on the heart during anesthesia and operation. A small quantity of atropine will inhibit salivary secretions. Scopolamine will accomplish this even better. When the problem is inhibition of the cardiac vagus, however, one encounters difficulty with the cardiac patient. The quani-tity of atropine needed to block the vagus adequately is often unsafe for the heart patient in that tachycardia and hypotension may be produced. If a patient is satisfactorily digitalized and the heart rate is slow, the administration of atropine may increase the pulse rate to hazardous levels. Large doses of atropine in addition to the muscarinic-blocking on the heart interfere also with ganglionic transmission in the autonomic nervous system. Thus the patient given a large dose of atropine may also evidence postural hypotension. 8 In the prevention of tachycardia a possible side effect of meperidine on cardiac rate must be considered. This drug, which is a good analgesic and similar in most respects to morphine, has the additional property of producing vagal block. There have been instances wherein the use of meperidine has precipitated a rapid atrial rate and heart failure when given to patients with slower rates and atrial flutter. 9 These details about preanesthetic medication are mentioned to emphasize their possible untoward effects in the cardiac patient who is about to undergo anesthesia. These drugs can and must be used with caution. In moderate dosage the barbiturates are safest for avoidance of apprehension. The interaction of the tranquilizing and anesthetic drugs has already been noted to produce undesirable side effects.5 Reserpine (Serpasil) because of the slow rate of excretion must be discontinued many days before anesthesia lest hypotension supervene. Atropine, unless employed for the treatment of patients with complete heart block, should be used sparingly for the effect on salivary secretion. The same precautions apply to the employment of morphine or meperidine unless they be needed for the relief of pain. Anesthetic problems may originate in any of the aforementioned phases of the operative experience. These problems have been briefly reviewed. The most important factor in minimizing the problems of anesthesia itself is the skill and knowledge with which the anesthetic agents are chosen and administered rather than the actual pharmacologic and physiologic effects of the agents themselves. On a background of thorough medical preparation safe anesthesia for the patient with heart disease consists of the careful selection of preanesthetic medication, flawless technic, and use of minimal quantities of anesthetic agents and adjuncts. Despite the attainment of these goals, circulatory and respiratory problems will be encountered. These may be related to the heart disease itself, to medical preparation, pharmacologic side effects, and to a multitude of undesirable respiratory and circulatory reflexes. The latter in turn reside in anesthetic and surgical manipulation. Knowledge of these factors enables the internist to understand the problems of anesthesia and to prepare the patient for the operative experience.
